Yasuto Yoneshima

2.1k total citations
54 papers, 944 citations indexed

About

Yasuto Yoneshima is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yasuto Yoneshima has authored 54 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Yasuto Yoneshima's work include Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Treatments and Mutations (20 papers) and Lung Cancer Research Studies (9 papers). Yasuto Yoneshima is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Treatments and Mutations (20 papers) and Lung Cancer Research Studies (9 papers). Yasuto Yoneshima collaborates with scholars based in Japan, United States and Spain. Yasuto Yoneshima's co-authors include Kentaro Tanaka, Yoichi Nakanishi, Isamu Okamoto, Eiji Iwama, Kohei Otsubo, Tetsuzo Tagawa, Yoshinao Oda, Kazuki Takada, Shinkichi Takamori and Mototsugu Shimokawa and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Yasuto Yoneshima

51 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuto Yoneshima Japan 17 669 482 177 101 84 54 944
Yusuke Chihara Japan 13 641 1.0× 435 0.9× 154 0.9× 114 1.1× 86 1.0× 60 898
Shinjiro Sakamoto Japan 16 331 0.5× 428 0.9× 135 0.8× 162 1.6× 43 0.5× 98 838
Martina Catalano Italy 16 323 0.5× 270 0.6× 215 1.2× 59 0.6× 91 1.1× 70 749
P. Cheema United States 11 347 0.5× 233 0.5× 224 1.3× 97 1.0× 80 1.0× 22 842
Lorenzo Calvetti Italy 9 361 0.5× 336 0.7× 96 0.5× 50 0.5× 113 1.3× 23 566
Akira Haro Japan 14 373 0.6× 448 0.9× 118 0.7× 62 0.6× 78 0.9× 42 750
M Kowalska Poland 16 448 0.7× 183 0.4× 231 1.3× 236 2.3× 109 1.3× 56 888
Yoshimasa Shiraishi Japan 17 435 0.7× 495 1.0× 156 0.9× 64 0.6× 92 1.1× 79 811
Ying Cheng China 12 457 0.7× 158 0.3× 157 0.9× 166 1.6× 67 0.8× 62 702
Jordi Rubió‐Casadevall Spain 13 363 0.5× 430 0.9× 139 0.8× 23 0.2× 71 0.8× 44 771

Countries citing papers authored by Yasuto Yoneshima

Since Specialization
Citations

This map shows the geographic impact of Yasuto Yoneshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuto Yoneshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuto Yoneshima more than expected).

Fields of papers citing papers by Yasuto Yoneshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuto Yoneshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuto Yoneshima. The network helps show where Yasuto Yoneshima may publish in the future.

Co-authorship network of co-authors of Yasuto Yoneshima

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuto Yoneshima. A scholar is included among the top collaborators of Yasuto Yoneshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuto Yoneshima. Yasuto Yoneshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nakamura, Shôji, Kazuya Tsubouchi, Yasuto Yoneshima, et al.. (2024). Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitis. Journal for ImmunoTherapy of Cancer. 12(12). e010114–e010114. 5 indexed citations
3.
Iwama, Eiji, et al.. (2024). TP53 gain-of-function mutations promote osimertinib resistance via TNF-α–NF-κB signaling in EGFR-mutated lung cancer. npj Precision Oncology. 8(1). 60–60. 13 indexed citations
4.
Yamamoto, Yoshihiro, Kohei Otsubo, Yoshimasa Shiraishi, et al.. (2024). Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review. Thoracic Cancer. 15(13). 1106–1111. 1 indexed citations
5.
Tanaka, Kentaro, et al.. (2023). YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells. Biochemical and Biophysical Research Communications. 681. 120–126.
6.
Shimokawa, Tsuneo, Hiroaki Okamoto, Ryunosuke Machida, et al.. (2023). Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial. Lung Cancer. 181. 107195–107195. 4 indexed citations
7.
Inui, Naoki, Yukihiro Toi, Yasuto Yoneshima, et al.. (2023). Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase. Advances in Therapy. 40(11). 4928–4944. 5 indexed citations
8.
Inoue, Hiroyuki, Yoshimasa Shiraishi, Hiroyuki Ando, et al.. (2023). Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors. Lung Cancer. 181. 107264–107264. 8 indexed citations
9.
Yoneshima, Yasuto, Koji Okamura, Toyoshi Yanagihara, et al.. (2023). MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma. Cancer Science. 114(10). 4101–4113. 4 indexed citations
10.
Iwama, Eiji, Hidetaka Yamamoto, Kayo Ijichi, et al.. (2023). Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer. Thoracic Cancer. 14(23). 2288–2296. 4 indexed citations
11.
Yoneshima, Yasuto, et al.. (2023). Pleuroparenchymal fibroelastosis secondary to autologous peripheral blood stem cell transplantation: A case report. Respiratory Medicine Case Reports. 43. 101845–101845. 1 indexed citations
12.
Okamura, Koji, Hiroyuki Inoue, Kentaro Tanaka, et al.. (2022). Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma. Cancer Science. 114(3). 1095–1107. 5 indexed citations
13.
Kijima, Takashi, Koichi Azuma, Hidetoshi Hayashi, et al.. (2022). P29-1 LIGHT-NING: An observational study of nivolumab plus ipilimumab with or without chemotherapy for 1st line NSCLC in Japan. Annals of Oncology. 33. S524–S524. 1 indexed citations
14.
Kenmotsu, Hirotsugu, Kazushige Wakuda, Keita Mori, et al.. (2022). Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study. Journal of Thoracic Oncology. 17(9). 1098–1108. 90 indexed citations
15.
Tanaka, Kentaro, Gouji Toyokawa, Kayo Ijichi, et al.. (2020). NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration. Lung Cancer. 146. 97–104. 22 indexed citations
16.
Tsuchimoto, Daisuke, Yoshinori Hayashi, Nona Abolhassani, et al.. (2020). Neural stem cell–specific ITPA deficiency causes neural depolarization and epilepsy. JCI Insight. 5(22). 8 indexed citations
17.
Yoneshima, Yasuto, Kentaro Tanaka, Yoshimasa Shiraishi, et al.. (2019). Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies. Lung Cancer. 130. 5–9. 45 indexed citations
18.
Akamine, Takaki, Kazuki Takada, Gouji Toyokawa, et al.. (2018). Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers. Surgical Oncology. 27(1). 88–94. 38 indexed citations
19.
Yoneshima, Yasuto, Isamu Okamoto, Shinichi Kimura, et al.. (2014). Infected complex renal cysts during crizotinib therapy in a patient with non–small cell lung cancer positive for ALK rearrangement. Investigational New Drugs. 33(2). 510–512. 9 indexed citations
20.
Yoneshima, Yasuto, et al.. (2009). [Three cases of pulmonary aspergilloma treated by cavernostomy and simultaneous removal of fungus balls].. PubMed. 47(10). 930–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Chihara Breakdown of academic impact, for papers by Shinjiro Sakamoto Breakdown of academic impact, for papers by Martina Catalano Breakdown of academic impact, for papers by P. Cheema Breakdown of academic impact, for papers by Lorenzo Calvetti Breakdown of academic impact, for papers by Akira Haro Breakdown of academic impact, for papers by M Kowalska Breakdown of academic impact, for papers by Yoshimasa Shiraishi Breakdown of academic impact, for papers by Ying Cheng Breakdown of academic impact, for papers by Jordi Rubió‐Casadevall
Rankless by CCL
2026